Phathom Pharmaceuticals I...

NASDAQ: PHAT · Real-Time Price · USD
10.26
-0.21 (-2.01%)
At close: Aug 15, 2025, 3:59 PM
10.24
-0.15%
After-hours: Aug 15, 2025, 06:01 PM EDT

Phathom Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-334.33M -201.59M -197.72M -143.88M
Depreciation & Amortization
795K 575K 620K 521K
Stock-Based Compensation
24.05M 45.02M 24.13M 16.81M
Other Working Capital
-6.93M -8.97M -3.24M -17.68M
Other Non-Cash Items
42.71M 32.06M 21M 5.41M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
n/a -13.64M 5.44M -27.48M
Operating Cash Flow
-266.77M -137.58M -146.53M -148.62M
Capital Expenditures
n/a -1.63M -1.04M -328K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-135K n/a -1.18M -330K
Investing Cash Flow
-135K -1.63M -1.04M -328K
Debt Repayment
59.4M 39.32M n/a 42.76M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.6M 172.8M 95.45M 1.94M
Financial Cash Flow
182.77M 367.58M 120.04M 44.71M
Net Cash Flow
-84.13M 228.37M -27.53M -104.24M
Free Cash Flow
-266.9M -139.21M -147.57M -148.94M